Peptide Initiative

Peptides · Peptide comparison

Human Chorionic Gonadotropin (HCG) vs Leuprolide

A powerful hormone that mimics luteinizing hormone (LH) to stimulate your body's natural testosterone production while keeping your fertility intact—like having your cake and eating it too for men on hormone therapy.

A powerful GnRH agonist that helps manage hormone-sensitive conditions by controlling hormone production.

  • Hormone Support
  • Hormone Support

At a glance

Quick comparison

Dose rangeHuman Chorionic Gonadotropin (HCG)500–1500 IULeuprolide1–1 mg
FrequencyHuman Chorionic Gonadotropin (HCG)Twice weeklyLeuprolideOnce daily
AdministrationHuman Chorionic Gonadotropin (HCG)Subcutaneous injectionLeuprolideSubcutaneous injection (daily)
Cycle lengthHuman Chorionic Gonadotropin (HCG)Ongoing/indefiniteLeuprolideOngoing/indefinite
Onset speedHuman Chorionic Gonadotropin (HCG)Moderate (1-2 weeks)LeuprolideModerate (1-2 weeks)
Evidence levelHuman Chorionic Gonadotropin (HCG)Strong human trials (Phase 3 or FDA approved)LeuprolideStrong human trials (Phase 3 or FDA approved)

Efficacy

Benefit ratings

Fertility Preservation

Human Chorionic Gonadotropin (HCG)95%
LeuprolideNo recorded rating

Testicular Health

Human Chorionic Gonadotropin (HCG)92%
LeuprolideNo recorded rating

Hormone Balance

Human Chorionic Gonadotropin (HCG)88%
LeuprolideNo recorded rating

Cancer Management

Human Chorionic Gonadotropin (HCG)No recorded rating
Leuprolide94%

Endometriosis & Fibroid Relief

Human Chorionic Gonadotropin (HCG)No recorded rating
Leuprolide90%

Hormone Control

Human Chorionic Gonadotropin (HCG)No recorded rating
Leuprolide87%

Technical data

Compound specifications

Human Chorionic Gonadotropin (HCG)

Molecular formula
C1105H1770N318O336S26 (approximate)
Molecular weight
36,700 g/mol (approximately)
Half-life
24-36 hours
Bioavailability
High when injected subcutaneously or intramuscularly
CAS number
9002-61-3

Leuprolide

Molecular formula
C59H84N16O12
Molecular weight
1209.4 g/mol
Half-life
Approximately 2-6 hours (varies by route of administration)
Bioavailability
~95% (subcutaneous injection)
CAS number
74381-53-6

Protocols

Dosing compared

Human Chorionic Gonadotropin (HCG)

Subcutaneous

  • 500-1,500 IU2-3 times per week · Ongoing with TRTDocumented clinical practice for preserving testicular function/fertility in men on testosterone therapy; 1,500-2,000 IU 2-3x/week is used for hypogonadotropic hypogonadism [6]. The popular 500 IU 2-3x/week maintenance figure reflects real-world practice rather than the FDA label. In controlled dosing, 250 IU every other day held intratesticular testosterone within 7% of baseline and 500 IU raised it 26% above baseline during testosterone administration [7]; 500 IU every other day preserved semen parameters with no azoospermia in men on TRT [8].

Intramuscular

  • 500-1,000 IU3 times weekly for 3 weeks, then 2 times weekly for 3 weeks · 6-week induction courseFDA-labeled regimen for male hypogonadotropic hypogonadism (Pregnyl) [7]. Intramuscular is the only labeled route.
  • 4,000 IU then taper to 2,000 IU3 times weekly · 4,000 IU for 6-9 months, then 2,000 IU for 3 additional monthsHigher-dose FDA-labeled regimen for inducing spermatogenesis/testicular descent (Pregnyl) [7].

Leuprolide

Subcutaneous

  • 1 mgOnce daily · OngoingThe original daily form is a 1 mg shot under the skin each day for advanced prostate cancer. It works but needs a shot every day, so most people now use the longer-acting depot instead [4].

Intramuscular

  • 7.5 mgEvery month · OngoingThe 1-month depot is a single 7.5 mg shot into the muscle every 4 weeks. One injection replaces a month of daily shots [5].
  • 22.5 mgEvery 3 months · OngoingThe 3-month depot is a 22.5 mg muscle injection given once every 3 months, so fewer office visits [5].
  • 30-45 mgEvery 4-6 months · OngoingThe longest-acting depots: 30 mg every 4 months, or 45 mg every 6 months. These need only 2-3 injections per year [5].

Applications

Best suited for

Human Chorionic Gonadotropin (HCG)

Fertility Preservation During TRT
If you're on testosterone therapy but want to keep your swimmers swimming, HCG is your best friend. It keeps your testes active and producing sperm even when external testosterone would normally shut that down. Research shows it can maintain or restore spermatogenesis in about 80% of men [3][4][8].
Preventing Testicular Atrophy
Nobody wants their boys to shrink. When you take external testosterone, your brain stops signaling your testes to work—and they get smaller from disuse. HCG mimics the signal (LH) that keeps them active, maintaining their size and function [6][14].
Hypogonadotropic Hypogonadism
If your pituitary gland isn't sending the right signals to your testes (low LH), HCG can step in and do the job. It's been used for decades to treat this condition, helping men achieve normal testosterone levels and fertility [3][6][13].
Post-Cycle Therapy (PCT)
After using anabolic steroids, your natural hormone production is suppressed. HCG can help jumpstart your testes back into action, speeding up the recovery of your natural testosterone production. It's often used as part of a comprehensive PCT protocol [9][15].

Leuprolide

Managing advanced or metastatic prostate cancer
Leuprolide is particularly well-suited for individuals focused on managing advanced or metastatic prostate cancer. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1][5].
Controlling severe endometriosis pain
Leuprolide is particularly well-suited for individuals focused on controlling severe endometriosis pain. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1].
Treating symptomatic uterine fibroids
Leuprolide is particularly well-suited for individuals focused on treating symptomatic uterine fibroids. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1].
Delaying early puberty in children
Leuprolide is particularly well-suited for individuals focused on delaying early puberty in children. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1].

Safety profile

Side effects

Human Chorionic Gonadotropin (HCG)

Common

  • Injection site reactions
  • Headache
  • Water retention

Uncommon

  • Gynecomastia
  • Mood changes
  • Acne

Serious

  • Blood clots

Leuprolide

Common

  • Hot flashes (very common in men)
  • Decreased libido and erectile dysfunction
  • Injection site pain or swelling
  • Nausea
  • Fatigue
  • Mood changes or depression
  • Joint or muscle pain
  • Headaches
  • Dizziness
  • Thinning hair
  • Decreased bone density (osteoporosis with long-term use)
  • QT prolongation (rare but serious cardiac effect)
  • Tumor flare (temporary worsening of cancer symptoms in first weeks)
  • Severe allergic reactions
  • Spinal cord compression risk in men with metastatic disease

Serious

  • Severe allergic reaction

Research status

Safety & evidence

Human Chorionic Gonadotropin (HCG)

Evidence level
Strong human trials (Phase 3 or FDA approved)
FDA status
FDA approved for other use
Safety overview
HCG has been used medically for over 80 years with a well-established safety profile. [10] When used appropriately for male hypogonadism or fertility preservation, side effects are generally mild and manageable. The most common issues relate to elevated estrogen from increased testosterone aromatization, which can be managed with aromatase inhibitors if needed. [6][18] Serious side effects are rare when HCG is used under medical supervision.

Contraindications

  • Hormone-sensitive cancers (prostate, breast) [6][23]
  • Precocious puberty in children [23]
  • Known allergy to HCG or any component [6][23]
  • Pregnancy (in therapeutic male contexts) [23]
  • Untreated thyroid or adrenal disorders [6]

Leuprolide

Evidence level
Strong human trials (Phase 3 or FDA approved)
FDA status
FDA approved for this use
Safety overview
Leuprolide (Lupron) is an FDA-approved GnRH agonist with 35+ years of clinical safety data involving millions of patients in oncology and endocrinology. [1] The critical safety issue is the initial 5-7 day flare effect—temporary surge in FSH/LH causing symptom worsening before hormone suppression begins—particularly dangerous for prostate cancer patients (flare can cause urinary obstruction or spinal cord compression). [5] Bone density loss is a dose-dependent long-term risk in both men and women requiring monitoring. [1][5] Injection site reactions, hot flushes, and initial hypogonadal symptoms are expected and typically transient. [5]

Contraindications

  • Pregnancy (may cause fetal harm) [6]
  • Undiagnosed vaginal bleeding [6]
  • Allergy to GnRH agonists or components [5][6]

Decision guide

Which is right for you?

Human Chorionic Gonadotropin (HCG)

Choose Human Chorionic Gonadotropin (HCG) if…

  • Fertility preservation during TRT
  • Maintaining testicular size and function
  • Natural testosterone stimulation
  • Post-cycle therapy recovery

Leuprolide

Choose Leuprolide if…

  • Managing advanced or metastatic prostate cancer
  • Controlling severe endometriosis pain
  • Treating symptomatic uterine fibroids
  • Delaying early puberty in children